Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-041491
Filing Date
2021-08-11
Accepted
2021-08-11 07:02:24
Documents
3
Period of Report
2021-08-11

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea145094-6k_kamadaltd.htm 6-K 18832
2 PRESS RELEASE, DATED AUGUST 11, 2021 ea145094ex99-1_kamada.htm EX-99.1 210112
3 KAMADA LTD.'S CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2021 (UNAUDITED) ea145094ex99-2_kamada.htm EX-99.2 669858
  Complete submission text file 0001213900-21-041491.txt   899779
Mailing Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402
Business Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402 97289406472
KAMADA LTD (Filer) CIK: 0001567529 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35948 | Film No.: 211161938
SIC: 2834 Pharmaceutical Preparations